Bank OZK (OZK) PT Lowered to $59 at Morgan Stanley

Morgan Stanley analyst Manan Gosalia lowered the price target on Bank OZK (NASDAQ: OZK) to $59.00 (from $63.00) while maintaining a Equalweight rating.

The analyst comments "Bank Ozk (OZK, EW). With Alexandria Real Estate Equities (ARE), a life science and technology REIT, highlighting in December that vacancies in life sciences real estate could remain elevated over the medium term, we've noted a renewed investor focus on OZK’s life sciences exposure. While we don't expect any changes given OZK's prior comments that sponsors continue to support their properties, any negative developments on credit could impact the stock on earnings day. In the medium term, our focus remains on OZK’s NII trajectory. We are 1% and 2% above consensus for 2026 and 2027 NII, respectively, on higher NIM."

You May Also Be Interested In

• Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
• Dover Corp. (DOV) PT Raised to $230 at Morgan Stanley
• BeWhere acquires SecureQuip Systems for $789,000 in cash